Veterinary/Animal Vaccines Companies

Latest Veterinary Vaccines Companies Update

• 
  May 2023: Hester Biosciences Ltd, a major leader in the animal healthcare industry, said it had acquired regulatory clearance for a Bio-Safety Level-III (BSL-3) facility intended for human vaccine development and manufacture. In response to declining demand for Covid vaccines, the business stated that it is "considering the repurposing of the facility to manufacture human or veterinary vaccines," meaning that the BSL-3 facility is operational. The Department of Biotechnology in India (BIRAC) would be consulted and give their stamp of approval before the final decision was made.

• 
  April 2022: The pharmaceutical giant Cadila Pharmaceuticals made headlines when it revealed the development of a revolutionary three-dose rabies vaccine. Using Virus-like Particle technology, the three-dose vaccination known as 'ThRabis' was developed, and the business announced its availability in a press release. Cadila Pharmaceuticals CMD said the new vaccine will be revolutionary because the current rabies vaccinations require five shots spaced out over 28 days to completely eliminate the threat (of virus spread). Rajiv Modi stated at the introduction ceremony of the new vaccination.

• 
  September 2022: Insect health and immunology pioneer Dalan Animal Health, Inc. closed a $3.55 million initial funding round in September 2022, with leading investors including At One Ventures and Veterinary Angel Network for Entrepreneurs (VANE). With this $5.5 million round of investment, the company has now raised $5.5 million overall from its two seed rounds. To help preserve their pollinators and advance sustainable agriculture, Dalan is dedicated to developing novel approaches.

• Zoetis (US)


• Virbac SA (France)


• Merck (US)


• Phibro Animal Health Corporation (US)


• Boehringer Ingelheim (Germany)


• Ceva (France)


• Elanco (US)